Skip to main content
Process

What are tumor markers?

Medcasts editorial team

Tumor markers are blood tests for substances elevated in some cancers. Common ones: PSA (prostate), CA-125 (ovarian), CA 19-9 (pancreatic), AFP (liver, testicular), CEA (colon), beta-HCG (testicular, gestational).

Limitations are important: tumor markers aren't typically used to diagnose cancer (false positives are common in non-cancer conditions). They're more useful for tracking response to treatment and monitoring for recurrence after treatment.

Baseline levels before treatment, mid-treatment, and post-treatment trends are the meaningful framing — not single values. Bring all your tumor marker values, not just the most recent.

This answer is general information, not medical advice. Your own doctor should confirm what applies to your case.

All questions

Want an answer for your own case?

Send your reports once. A doctor reviews them and you get written quotes from up to 3 hospitals, free.

How this page is made

Methodology and editorial standards

Answers are written by the Medcasts editorial team and updated when prices, guidelines or visa rules change.

  1. Hospital data. Hospital details are compiled from public sources and hospital websites. Accreditation (JCI, NABH and others) is shown where we hold a record of it. Always ask the hospital for its current certificate.
  2. Doctor credentials. Qualifications, specialty and bio come from the doctor's hospital profile. Licence is checked against the national medical-council register only where the profile shows a "Licence verified" badge with a date.
  3. Prices. Price ranges are indicative, compiled from hospital price lists and packages and shown with the date last updated. The hospital's written quote is what you pay against.
  4. Clinical text. Written by the Medcasts editorial team from published clinical sources. Unless a named reviewer is shown on the page, it has not been reviewed by a doctor.
  5. Independence. Hospitals cannot pay to change their position on our pages.